Centene's share price plummeted 40% after guidance withdrawal. Investors fear Centene misled them about its actuarial practices. A preliminary analysis revealed a $1.8 billion revenue reduction. Hagens Berman launched an investigation into possible securities law violations. The company's reputation may face long-term damage from this incident.
A 40% price drop indicates severe loss of investor confidence, reminiscent of similar past incidents leading to long-term declines in share value.
The reputation damage and potential legal implications may deter future investments and recovery.
The significant share price drop combined with ongoing investigations suggests a major impact on CNC.